Phase II Study of Azacitidine in Myelofibrosis.

Trial Profile

Phase II Study of Azacitidine in Myelofibrosis.

Phase of Trial: Phase II

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Myelofibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jan 2011 Status changed from completed to discontinued as reported by
    • 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by
    • 17 Dec 2007 The expected completion date for this trial is now 1 Dec 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top